User profiles for Raúl Tonda
Raul TondaCentro Nacional de Análisis Genómico - CNAG Verified email at cnag.eu Cited by 1446 |
[PDF][PDF] PrecisionFDA Truth Challenge V2: Calling variants from short and long reads in difficult-to-map regions
The precisionFDA Truth Challenge V2 aimed to assess the state of the art of variant calling
in challenging genomic regions. Starting with FASTQs, 20 challenge participants applied …
in challenging genomic regions. Starting with FASTQs, 20 challenge participants applied …
Heterozygous STUB1 mutation causes familial ataxia with cognitive affective syndrome (SCA48)
…, L de Jorge, E López, B Campos, E Lorenzo, R Tonda… - Neurology, 2018 - AAN Enterprises
Objective To describe a new spinocerebellar ataxia (SCA48) characterized by early cerebellar
cognitive-affective syndrome (CCAS) and late-onset SCA. Methods This is a descriptive …
cognitive-affective syndrome (CCAS) and late-onset SCA. Methods This is a descriptive …
Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes
I Del Conde, F Nabi, R Tonda… - … , and vascular biology, 2005 - Am Heart Assoc
Objective— Stimulation of monocytes with P-selectin induces the synthesis of an array of
mediators of inflammation, as well as the expression of tissue factor (TF), the main initiator of …
mediators of inflammation, as well as the expression of tissue factor (TF), the main initiator of …
A critical spotlight on the paradigms of FFPE-DNA sequencing
…, M Gut, N Arnold, JR Trotta, R Tonda… - Nucleic Acids …, 2023 - academic.oup.com
In the late 19th century, formalin fixation with paraffin-embedding (FFPE) of tissues was
developed as a fixation and conservation method and is still used to this day in routine clinical …
developed as a fixation and conservation method and is still used to this day in routine clinical …
[HTML][HTML] Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer
L Feliubadaló, R Tonda, M Gausachs, JR Trotta… - Scientific reports, 2017 - nature.com
Next generation sequencing panels have been developed for hereditary cancer, although
there is some debate about their cost-effectiveness compared to exome sequencing. The …
there is some debate about their cost-effectiveness compared to exome sequencing. The …
Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome
…, M Garrote, RM Risueño, R Tonda… - Blood …, 2023 - ashpublications.org
Germ line predisposition in acute myeloid leukemia (AML) has gained attention in recent
years because of a nonnegligible frequency and an impact on management of patients and …
years because of a nonnegligible frequency and an impact on management of patients and …
[HTML][HTML] Runs of homozygosity reveal signatures of positive selection for reproduction traits in breed and non-breed horses
Background Modern horses represent heterogeneous populations specifically selected for
appearance and performance. Genomic regions under high selective pressure show …
appearance and performance. Genomic regions under high selective pressure show …
[HTML][HTML] Solving patients with rare diseases through programmatic reanalysis of genome-phenome data
Reanalysis of inconclusive exome/genome sequencing data increases the diagnosis yield of
patients with rare diseases. However, the cost and efforts required for reanalysis prevent its …
patients with rare diseases. However, the cost and efforts required for reanalysis prevent its …
The RD‐Connect Genome‐Phenome Analysis Platform: Accelerating diagnosis, research, and gene discovery for rare diseases
…, J Protasio, R Thompson, R Tonda… - Human …, 2022 - Wiley Online Library
Rare disease patients are more likely to receive a rapid molecular diagnosis nowadays
thanks to the wide adoption of next‐generation sequencing. However, many cases remain …
thanks to the wide adoption of next‐generation sequencing. However, many cases remain …
[HTML][HTML] Systematic collaborative reanalysis of genomic data improves diagnostic yield in neurologic rare diseases
Many patients experiencing a rare disease remain undiagnosed even after genomic testing.
Reanalysis of existing genomic data has shown to increase diagnostic yield, although there …
Reanalysis of existing genomic data has shown to increase diagnostic yield, although there …